Metabolic indicators of patients with heart disease are being analyzed in different countries, and trimethylamine-N-oxide is found to be in high concentration in people with high cardiovascular risk factors.

trimethylamine-N oxidе(ТМАО), arterial pressure, ultrasound examination, electrocardiography, hepatosis, cholecystitis, arrhythmia

Zeisel, S.H.; daCosta, K.A.; Youssef, M.; Hensey, S. Conversion of dietary choline to trimethylamine and dimethylamine in rats: Dose-response relationship. J. Nutr. 1989, 119, 800–804.

Zhu, W.; Gregory, J.C.; Org, E.; Buffa, J.A.; Gupta, N.; Wang, Z.; Li, L.; Fu, X.; Wu, Y.; Mehrabian, M.; et al. Gut microbial metabolite TMAO enh Chen ML, Yi L, Zhang Y, Zhou X, Ran L, Yang J, Zhu JD, Zhang QY, Mi MT. Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota. mBio. 2016 Apr 5;7(2):e02210-15. doi: 10.1128/mBio.02210-15. PMID: 27048804; PMCID: PMC4817264

Chen, D.; Jin, D.; Huang, S.; Wu, J.; Xu, M.; Liu, T.; Dong, W.; Liu, X.; Wang, S.; Zhong, W. Clostridium butyricum, a butyrate-producing probiotic, inhibits intestinal tumor development through modulating Wnt signaling and gut microbiota. Cancer Lett. 2020, 469, 456–467

Cheung K., Lee S. S., Raman M. Prevalence and mechanisms of malnutrition in patients with advanced liver disease, and nutrition management strategies //Clinical Gastroenterology and Hepatology. – 2012. – V. 10. – №. 2. – P. 117-120

DiNicolantonio J. J., Lavie C. J., Fares H., Menezes A. R., O'Keefe J. H. L-carnitine in the secondary prevention of cardiovascular disease: systematic review and meta-analysis // Mayo Clin Proc. ‒ 2013. ‒ Vol. 88, № 6. ‒ P. 544-551

Ebel, B.; Lemetais, G.; Beney, L.; Cachon, R.; Sokol, H.; Langella, P.; Gervais, P. /Impact of probiotics on risk factors for cardiovascular diseases// A review. Crit. Rev. Food Sci. Nutr. 2014, 54, 175–189;